###### Strengths and limitations of this study

-   Longitudinal study design with a data linkage between two case register systems in London, UK.

-   Mortality information was retrieved from the national registry of death certificates in the UK.

-   The completeness rate of cancer stage was about 65%, which is within the range reported by other cancer registries in England and did not differ for most of the mental disorder groups of research interest compared with the remaining population.

-   Lack of lifestyle factors (smoking, drinking, diet, obesity and physical activities) for confounding control in survival analysis.

-   Small numbers of cancer cases with some specific mental disorders did not permit restricting the sample for sensitivity analyses. Also, size of the linked sample also did not allow further analyses of individual cancer diagnoses.

Introduction {#s1}
============

Numerous studies have indicated a higher risk of all-cause mortality and shorter life expectancy for people with severe mental illness (SMI), including schizophrenia, bipolar disorder, schizoaffective disorder and, sometimes, depressive disorders.[@R1] The profile of causes of death among people with SMI is not substantially different from that in general population, although some specific patterns of death have been suggested, differing by sex, age group and mental disorder diagnosis.[@R3] [@R5] [@R9] In recent decades, cardiovascular disease, stroke, respiratory diseases, suicide and cancer have remained the leading causes.[@R3] [@R5] [@R9]

A recent population-based study revealed that men with psychiatric admissions before cancer registration had a significantly worse survival, especially for those with depressive disorders, neurotic and adjustment disorders, and alcohol-related or other substance use disorders.[@R14] Results from three population-based cohort studies showed significantly increased cancer mortality among people with schizophrenia for both genders,[@R5] [@R9] [@R15] but some other studies reported that it occurred in men[@R7] [@R13] [@R16] [@R17] or women only.[@R18] However, other studies found no association with cancer mortality for SMI as a whole or schizophrenia specifically[@R7] [@R13] [@R16] [@R17] and even a reduced risk was reported in one study.[@R6] Depression has also been found to be associated with an increase in cancer mortality.[@R18] Studies of the incidence of cancer in people with SMI have principally focused on schizophrenia with varying results, including reduced total cancer incidence,[@R19][@R25] no difference[@R26] or increased risk.[@R30] A meta-analysis pooling eight studies concluded no association between schizophrenia and incidence of cancer.[@R27] A history of depression or alcohol-related or substance use disorders has been associated with increased cancer,[@R31] but inconsistent findings have been found for bipolar disorder,[@R32] [@R33] dementia[@R15] [@R18] [@R34] and null for schizoaffective disorder.[@R29] Evidence on the role of mental disease as a comorbidity factor in cancer is, therefore, still far from conclusive, but tends to indicate cancer incidence that is either reduced or not different, and cancer mortality that is increased.[@R32] [@R33]

Thinking of how to solve the puzzle shown on conflicting research results and effects of mental disorders to cancer prognosis, there are two key research questions to be answered. First, to what extent might the reduced recognition of early cancer symptoms in people with mental disorders influence the stage of cancer at diagnosis?[@R33] [@R35] And, second, what is the role of mental disorders on mortality after cancer diagnosis if the issue of later presentation of cancer could be ruled out? Then, an influence of mental disorders on cancer mortality in the absence of a clear effect on underlying risk could be explained by differences in treatment access, response and adherence, as previously raised by Kisely *et al*.[@R15] [@R38] Utilising a data linkage between a large secondary mental healthcare case register in southeast London and the regional cancer registry, we sought to investigate associations between mental disorder and disease stage at cancer diagnosis and subsequent survival.

Materials and methods {#s2}
=====================

The South London and Maudsley NHS Foundation Trust Biomedical Research Centre Case Register {#s2a}
-------------------------------------------------------------------------------------------

The South London and Maudsley NHS Foundation Trust (SLAM) Biomedical Research Centre (BRC) Case Register was used to provide data on mental disorders for the current study. SLAM is the near-monopoly provider of comprehensive secondary mental health services for a geographic catchment consisting of four London boroughs (Southwark, Lambeth, Lewisham and Croydon) with approximately 1.23 million residents. Clients' records for all the services provided by SLAM were electronised in 2006. In 2008, the Clinical Record Interactive Search (CRIS) system was developed as a platform for investigators to search and access full but anonymised clinical data from the fully electronic health records system in SLAM for research purposes. All people receiving SLAM care for psychiatric assessments and/or treatment were included in the database. The demographic characteristics and clinical profiles of the Case Register population have been fully described elsewhere.[@R39]

Thames Cancer Registry {#s2b}
----------------------

At the time of the study, Thames Cancer Registry (TCR) was the largest of eight population-based cancer registries in England, covering a population of 12 million residents in London, Kent, Surry and Sussex. Registration was initiated by pathology reports and clinical records from hospitals and information on death certificates were received from the National Health Service (NHS) Central Register through the Office of National Statistics in 1999. When cancer is recorded as the main or contributing cause of death in Part 1 section, the certificate is routinely sent to the regional cancer registry. Further information on demographic, clinical details and treatments received within the first 6 months after cancer diagnosis was retrieved from hospitals or hospital databases by trained data collection officers. A central regional database was maintained with data added continuously and robust data quality controls. To avoid double counting, information about new tumours was cross-checked against existing registered cases. Cancer registration and cancer surveillance take place in English registries under provisions of Section 251 of the Health and Social Care Act and this permission is reviewed annually. The TCR was assessed to be more than 95% complete in 2001--2007, and considered as of sufficient quality for cancer outcome analyses.[@R40] [@R41]

Anonymised process of data linkage {#s2c}
----------------------------------

Data from CRIS and TCR for residents in the SLAM geographic catchment were linked using an anonymisation process by the Health Research Support Service (HRSS) Pilot Programme which was operated by the Department of Health as part of the NHS Research Capability Programme in the UK. Memoranda of Understanding were signed between SLAM and TCR through HRSS, which in turn designed and created an infrastructure to provide a safe and confidential platform for health research. With HRSS as the 'trusted third party', the linkage was performed using a series of identifiers including the NHS number, and was then irreversibly deidentified, replacing the NHS number with an encrypted HRSS identification (HRSS id). The initial sample selected for analysis comprised individuals on the TCR dataset within SLAM coverage area. Thus, a retrospective cohort study of people under the care of secondary mental health services could be performed.

Covariates included {#s2d}
-------------------

Mental disorder diagnoses were identified from two sources within CRIS: (1) a primary psychiatric diagnosis (Axis 1a) categorised by International Classification of Diseases (ICD)-10 code (a structured field, compulsory for completion by services, with a specific date in the electronic clinical records system) and (2) a supplementary natural language processing application developed using General Architecture for Text Engineering (GATE) software which extracts text strings relating to a diagnosis statement in correspondence fields. The first diagnoses from either one or both sources were then categorised into the following groupings (ICD codes): dementia (F00--03), substance use disorders (F10--19), schizophrenia (F20), schizoaffective disorder (F25), bipolar disorder (F31), depressive disorders (F32--33), anxiety disorders (F40--42) and personality disorders (F60--61). SMI was defined as a diagnosis of schizophrenia (F20), schizoaffective disorder (F25) or bipolar disorder (F31). In the TCR data, tumour stage at presentation of cancer was routinely extracted from an individual\'s medical records and categorised as follows: 'local' (stage 1), 'extension beyond the organ of origin' (stage 2), 'regional lymph node involvement' (stage 3) and 'metastasis' (stage 4). Cases without sufficient information about disease stage were classified as 'not known'. Date of cancer diagnosis, date of birth, sex, type of cancer, primary care trust (geographic area) and ethnic group were also routinely collected in TCR and were used as covariates. In addition, the income domain of the index of multiple deprivations in 2007 was derived on the basis of the residential postcode.[@R42]

Statistical analysis {#s2e}
--------------------

All the cancer cases diagnosed in the period from 1999 to 2008 in residents of the catchment area of four London boroughs under SLAM service coverage were included in the current analyses. Through the linkage performed by HRSS, any cancer detected after a contact with SLAM was marked. If multiple tumours were registered in one person, only the first cancer onset was considered. Their primary psychiatric diagnosis given in SLAM services before the cancer was identified (if any) as the major exposure of interest in the current analyses. Stage of disease at cancer diagnosis was categorised into two groups: (1) early stage with no spread or only local extension beyond the organ of origin (localised stage) and (2) late stages with regional lymph node involvement or metastasis (advanced stage). This was treated as a binary dependent variable and was modelled against mental disorder diagnoses by logistic regressions. Cox regression models were then assembled to estimate the associations between mental disorder and survival after cancer diagnosis. The duration of follow-up was defined as the period from cancer diagnosis to the date of death (any cause) or the end of the follow-up period (12 June 2010), provided by TCR. Age at cancer diagnosis, gender, type of cancer, year of cancer diagnosis, primary care trust (geographic area), ethnic groups, deprivation score for income and stage at cancer diagnosis were treated as potential confounders, where appropriate. Area-level deprivation score for income was classified into quintiles, with the first quintile representing the most affluent areas and applied as the reference group in modelling. Stata/IC V.12.1 software for Windows (Stata Corporation, 2011) was used for all the analyses.

Results {#s3}
=======

The study sample {#s3a}
----------------

A total of 43 746 cancer cases were identified from TCR records. Among them, 15 166 participants (34.7%) had no information about their stage of cancer at diagnosis. No significant associations were found between psychiatric diagnosis and missing cancer stage data apart from a higher proportion of missing data in people with dementia (46.8%) compared with the remainder (35%). After the exclusion of people without confirmed cancer stage information and those younger than 15 years at cancer diagnosis (n=101), with missing date of birth (n=1) or date of cancer diagnosis (n=1), 28 477cases (65.1%) remained and were included in our analyses. Among them, 55.3% were women. Up to the end of 2008, a total of 2206 of these cancer cases had received any SLAM service (ie, were present on the CRIS database), and 125 of these had received an SMI diagnosis prior to their cancer diagnosis.

Factors associated with extent of disease at cancer diagnosis {#s3b}
-------------------------------------------------------------

Of the analysed sample of cancer cases, 64.2% (n=18 290) were diagnosed with localised stage of disease. Descriptive characteristics of the sample by stage at cancer diagnosis are presented in [table 1](#BMJOPEN2013004295TB1){ref-type="table"}. Participants with advanced stage of cancer at diagnosis were older and more likely to be men (both p values \<0.001), and there was significant variation by cancer type, year of diagnosis, primary care trust and ethnic group (all p values \<0.001), although no clear linear trend for socioeconomic deprivation was evident (details not shown).

###### 

Descriptive statistics of patients with cancer in southeast London by stage at cancer presentation from 1999 to 2008

                                    Number (%)/mean±SD                                   
  --------------------------------- -------------------- ---------------- -------------- ---------
  Age at cancer diagnosis (years)   63.31±17.96          60.38±19.15      66.80±14.29    \<0.01‡
  Gender                                                                                 \<0.01‡
   Female                           23 242 (53.49)       10 257 (56.08)   5490 (53.89)   
   Male                             20 212 (46.51)       8033 (43.92)     4697 (46.11)   
  Type of cancer                                                                         \<0.01‡
   Lung                             5286 (12.16)         1724 (9.43)      2068 (20.30)   
   Bladder                          1170 (2.69)          636 (3.48)       111 (1.09)     
   Breast                           5943 (13.68)         2592 (14.17)     1833 (17.99)   
   Skin                             2189 (5.04)          1548 (8.46)      93 (0.91)      
   Prostate                         4975 (11.45)         2657 (14.53)     634 (6.22)     
   Corpus uteri                     804 (1.85)           485 (2.65)       121 (1.19)     
   Colorectal                       3979 (9.16)          1441 (7.88)      1531 (15.03)   
   Others                           19 108 (43.97)       7207 (39.40)     3796 (37.26)   
  Ethnicity                                                                              \<0.01‡
   White                            26 055 (59.96)       10 766 (58.86)   6797 (66.72)   
   Black                            5080 (11.69)         2293 (12.54)     1293 (12.69)   
   East Asian                       541 (1.24)           222 (1.21)       135 (1.33)     
   South Asian                      804 (1.85)           258 (1.41)       173 (1.70)     
   Others/unknown/mixed             10 974 (25.25)       4751 (25.98)     1789 (17.56)   
  Deprivation score (income)                                                             \<0.01‡
   1st quintile                     2465 (5.67)          709 (3.88)       417 (4.09)     
   2nd quintile                     3308 (7.61)          1098 (6.00)      629 (6.17)     
   3rd quintile                     6520 (15.00)         2844 (15.55)     1355 (13.30)   
   4th quintile                     14 114 (32.48)       6130 (33.52)     3308 (32.47)   
   5th quintile                     17 047 (39.23)       7509 (41.06)     4478 (43.96)   

\*Participants with demographic information.

†Independent t tests for continuous variables and χ^2^ tests for categorical variables.

‡Statistical significance.

Mental disorder and stage at cancer diagnosis {#s3c}
---------------------------------------------

Associations between preceding mental disorders and stage at cancer diagnosis are summarised in [table 2](#BMJOPEN2013004295TB2){ref-type="table"}. In summary, findings were null and there was no evidence of an association with any diagnostic group after adjustment for age, gender, type of cancer, year of cancer diagnosis, primary care trust, ethnicity and deprivation score for income.

###### 

Associations between previous diagnosis received in secondary mental healthcare and stage at cancer diagnosis (N=28 477)

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variables                  Cancer stage at diagnosis\   Unadjusted OR for advanced cancer stage\   Age- and gender-adjusted OR for advanced cancer stage\   Fully adjusted OR for advanced cancer stage\*\   
                             N (%)                        (95% CI)                                   (95% CI)                                                 (95% CI)                                         
  -------------------------- ---------------------------- ------------------------------------------ -------------------------------------------------------- ------------------------------------------------ ---------------------
  SMI†                                                                                                                                                                                                         

   No                        18 208 (64.22)               10 144 (35.78)                             Ref                                                      Ref                                              Ref

   Yes                       82 (65.60)                   43 (34.40)                                 0.94 (0.65 to 1.36)                                      1.01 (0.70 to 1.47)                              0.94 (0.64 to 1.39)

  Schizophrenia                                                                                                                                                                                                

   No                        18 233 (64.24)               10 151 (35.76)                             Ref                                                      Ref                                              Ref

   Yes                       57 (61.29)                   36 (38.71)                                 1.13 (0.75 to 1.72)                                      1.23 (0.81 to 1.88)                              1.10 (0.71 to 1.71)

  Bipolar disorder                                                                                                                                                                                             

   No                        18 266 (64.21)               10 180 (35.79)                             Ref                                                      Ref                                              Ref

   Yes                       24 (77.42)                   7 (22.58)                                  0.52 (0.22 to 1.22)                                      0.55 (0.24 to 1.30)                              0.60 (0.25 to 1.42)

  Schizoaffective disorder                                                                                                                                                                                     

   No                        18 286 (64.22)               10 186 (357.8)                             Ref                                                      Ref                                              Ref

   Yes                       4 (80.0)                     1 (20.0)                                   0.45 (0.05 to 4.02)                                      0.47 (0.05 to 4.38)                              0.47 (0.04 to 4.95)

  Depression                                                                                                                                                                                                   

   No                        18 184 (64.22)               10 129 (35.78)                             Ref                                                      Ref                                              Ref

   Yes                       106 (64.63)                  58 (36.37)                                 0.98 (0.71 to 1.35)                                      0.91 (0.66 to 1.26)                              0.90 (0.64 to 1.27)

  Dementia                                                                                                                                                                                                     

   No                        18 229 (64.26)               10 137 (35.74)                             Ref                                                      Ref                                              Ref

   Yes                       61 (54.95)                   50 (45.05)                                 1.47 (1.01 to 2.14)‡                                     1.00 (0.68 to 1.46)                              1.23 (0.82 to 1.85)

  Substance use disorders                                                                                                                                                                                      

   No                        18 260 (64.23)               10 171 (35.77)                             Ref                                                      Ref                                              Ref

   Yes                       30 (65.22)                   16 (34.78)                                 0.96 (0.52 to 1.76)                                      1.01 (0.55 to 1.87)                              0.99 (0.52 to 1.89)

  Anxiety disorders                                                                                                                                                                                            

   No                        18 263 (64.22)               10 173 (35.78)                             Ref                                                      Ref                                              Ref

   Yes                       27 (65.85)                   14 (34.14)                                 0.93 (0.49 to 1.78)                                      0.98 (0.51 to 1.89)                              1.15 (0.58 to 2.28)

  Personality disorders                                                                                                                                                                                        

   No                        18 282 (64.24)               10 179 (35.76)                             Ref                                                      Ref                                              Ref

   Yes                       8 (50.00)                    8 (50.00)                                  1.80 (0.67 to 4.79)                                      2.15 (0.80 to 5.76)                              1.78 (0.65 to 4.88)
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Adjust for age, gender, type of cancer, year of cancer diagnosis, primary care trust, ethnicity and deprivation score for income.

†SMI: schizophrenia, bipolar disorder or schizoaffective disorder.

‡Statistical significance.

SMI, severe mental illness.

Mental disorder and survival after cancer diagnosis {#s3d}
---------------------------------------------------

Associations between mental disorders and survival after cancer diagnosis are summarised in [table 3](#BMJOPEN2013004295TB3){ref-type="table"}. SMI as a whole (and schizophrenia and schizoaffective disorder individually), depression, dementia and substance use disorders were associated with worse survival after cancer diagnosis in fully adjusted models, with a relatively little attenuation following adjustment for stage at cancer diagnosis.

###### 

Crude and adjusted relative risks for the effect of pre-existing mental disorders on general mortality among patients with cancer in southeast London by Cox models (N=43 449)

  Variables                  HR (95% CI)                                   
  -------------------------- ---------------------- ---------------------- ----------------------
  SMI‡                                                                     
   No                        Ref                    Ref                    Ref
   Yes                       1.53 (1.27 to 1.85)§   1.71 (1.44 to 2.06)§   1.74 (1.44 to 2.10)§
  Schizophrenia                                                            
   No                        Ref                    Ref                    Ref
   Yes                       1.71 (1.38 to 2.11)§   1.91 (1.55 to 2.37)§   1.90 (1.54 to 2.36)§
  Bipolar disorder                                                         
   No                        Ref                    Ref                    Ref
   Yes                       1.01 (0.66 to 1.55)    1.13 (0.74 to 1.73)    1.20 (0.78 to 1.85)
  Schizoaffective disorder                                                 
   No                        Ref                    Ref                    Ref
   Yes                       3.22 (1.45 to 7.17)§   2.69 (1.21 to 5.98)§   2.33 (1.05 to 5.20)§
  Depression                                                               
   No                        Ref                    Ref                    Ref
   Yes                       1.22 (1.04 to 1.44)§   1.27 (1.07 to 1.49)§   1.30 (1.11 to 1.54)§
  Dementia                                                                 
   No                        Ref                    Ref                    Ref
   Yes                       1.36 (1.17 to 1.58)§   1.65 (1.42 to 1.92)§   1.66 (1.43 to 1.94)§
  Substance use disorders                                                  
   No                        Ref                    Ref                    Ref
   Yes                       1.24 (0.89 to 1.72)    1.41 (1.02 to 1.96)§   1.42 (1.02 to 1.97)§
  Anxiety disorders                                                        
   No                        Ref                    Ref                    Ref
   Yes                       0.74 (0.50 to 1.10)    0.86 (0.58 to 1.30)    0.73 (0.49 to 1.10)
  Personality disorders                                                    
   No                        Ref                    Ref                    Ref
   Yes                       1.65 (0.94 to 2.91)    1.58 (0.90 to 2.79)    1.50 (0.85 to 2.64)

\*Model 1: adjusted for age, gender, type of cancer, year of cancer diagnosis, primary care trust, ethnicity and deprivation score for income.

†Model 2: adjusted for age, gender, type of cancer, year of cancer diagnosis, primary care trust, ethnicity, deprivation score for income and stage at cancer diagnosis.

‡SMI: schizophrenia, bipolar disorder or schizoaffective disorder.

§Statistical significance.

SMI, severe mental illness.

Discussion {#s4}
==========

Main findings {#s4a}
-------------

This linkage between a population-based cancer register and a near-monopoly secondary mental health service provider with a geographic catchment of approximately 1.23 million residents provided a sufficiently large sample for this investigation. The key findings were that people who had been diagnosed with specific mental disorders in the secondary mental health service were not more likely to have cancer with advanced stage at diagnosis, but that many of the mental disorder groups had worse subsequent survival. This latter finding was significant for SMI as a whole, and for schizophrenia and schizoaffective disorder individually, as well as for those with diagnoses of depression, dementia and substance use disorders prior to the cancer diagnosis. The stage of cancer at diagnosis in people with mental disorders did not explain their worse subsequent survival.

Advantages and limitations {#s4b}
--------------------------

The study described benefited from the large size of the two data sources. The linkage allowed the longitudinal observation of a substantial number of cases with mental disorder diagnoses who had subsequently developed cancer, and comparison group of the remaining people with cancer diagnoses from the same geographic catchment area. Ascertainment of vital status and deaths was achieved by linkage to death certificates provided electronically from the Office for National Statistics. Limitations include a fairly large proportion with missing data on cancer stage (34.7%). This completeness level is within the range reported by other English registries and represents the data available to the registration process. These levels have been improving with the receipt of electronic pathology data from hospitals. Importantly, the proportions with missing stage data did not differ for most of the mental disorder groups of primary interest compared with the remaining population (the only exception being dementia), and principal findings are therefore unlikely to have been biased by availability of stage information. The other issue was the lack of lifestyle factors for smoking, drinking, diet, obesity and physical activities in our dataset, which made further confounding control inapplicable. Another limitation was that some of the required data on mental disorders were drawn from years when there was less than full information, since electronic records became comprehensive across all SLAM services during 2006; however, the numbers of cases did not permit restricting the sample any further for sensitivity analyses. The size of the linked sample also did not permit analyses of individual cancer diagnoses. Besides, the significant finding of schizoaffective disorder for survival after cancer diagnosis in [table 3](#BMJOPEN2013004295TB3){ref-type="table"} was based on five cases only.

Comparisons with related studies {#s4c}
--------------------------------

In the relatively scarce literature about potentially delayed cancer diagnoses among people with mental disorders, the most recent published study reported a significantly higher proportion of metastasis at cancer presentation for psychiatric patients compared with general population (7.1% vs 6.1%) in Western Australia, especially for the cancer of breast and lung.[@R15] A US study, linking Surveillance, Epidemiology and End Results data to Medicare, found that people without mental disorder were slightly more likely to have an earlier detection of colon cancer than people who had any mental disorder (53.3% vs 49.7%), although it was partially contributed by higher proportion with unknown stage when colon cancer was diagnosed (6.2% vs 14.6%). The frequency of diagnosis at autopsy for colon cancer among people without mental disorder was also significantly lower than cases (1.1% vs 4.4%).[@R35] However, these two studies did not adjust for potential confounders in their analyses, especially for type of cancer.[@R15] [@R35] Another study focusing on breast cancer with confounders adjusted found that a history of major depression was associated with a delayed diagnosis of breast cancer representing an almost 10-fold increased risk, but the opposite direction of association was found for phobia.[@R43] Although we should have sufficient statistical power to identify the differences, our null findings for people undergoing assessment and treatment in secondary mental health services made the issue about delayed diagnosis of cancer among people with mental illness still inconclusive. Although potential explanation about specific psychological characteristics of dispositional insensitivity to threat (if the relation really exists) was found to be associated with delayed help seeking for symptoms of rectal cancer,[@R36] further in-depth investigations on the effect of mental disorders to physical healthcare utilisations are needed.

On the issue of survival for people with mental disorders after cancer diagnosis, a previous study of a population-based male Swedish cohort with psychiatric admissions before cancer diagnosis by registration found significantly worse survival, especially for those who had had depressive disorders, neurotic and adjustment disorders, and alcohol-related or other substance use disorders.[@R14] With a similar study design, Kisely *et al*[@R38] identified a significantly elevated risk of cancer mortality for people with psychiatric disorder in Canada. Advanced analyses exploring the reasons for elevated all-cause mortality following cancer diagnosis were also reported for people with known mental disorders in Western Australia, finding a reduced likelihood of surgery after diagnosis of colorectal, breast and cervical cancers in people with mental disorders and less radiotherapy or chemotherapy receipt.[@R15] The US linkage between Surveillance, Epidemiology and End Results data and Medicare found that receipt of colon cancer treatment (any treatment at all stages or chemotherapy at stage 3 only) was significantly lower for people with pre-existing any mental disorder, mood disorder, psychiatric disorder and dementia.[@R35] Our study provided additional support to the finding that, although the stage of diagnosis for cancer of people with mental illness was not more advanced, these people were still at higher risk of death compared with their counterparts without mental illness. The underlying reasons might differ by medical care system in countries. Further details about the treatment trajectories after cancer diagnosis for people with mental disorder are needed for advanced studies.

Implications and direction for future studies {#s4d}
---------------------------------------------

The wider question about cancer risk and outcome in people with mental disorders has received considerable attention over the years, although studies have principally investigated overall cancer-related mortality or cancer incidence. While findings about cancer screening uptake rates among people with SMI were inconsistent across and within countries,[@R44] one possible reason for reasonably consistent raised cancer-related mortality in people with mental disorders but inconsistent evidence for raised cancer incidence is that the mortality is explained by delays in presentation rather than increased risk. However, we found no evidence that prior mental disorder was associated with more advanced stage of cancer at diagnosis, a measure of delay in presentation, which might be because that, in the UK, since 2003, general practitioners have been incentivised under the guide of Quality and Outcomes Framework[@R45] to offer regular physical health reviews to people with long-term mental health problems, including preventative cancer screening appropriate to age and gender since 2006.

Instead, consistent with other findings,[@R14] [@R15] [@R35] [@R38] we found an association with worse survival after cancer diagnosis that was not explained by stage at presentation. This suggests that effects of mental disorder on cancer mortality primarily exert themselves after the diagnosis. Causal pathways might include reduced access to medical treatment and care, differing decisions about or tolerance of intensive regimes, and the influence of other health problems or drug effects on survival. Also, there might be differences between cancers on the impact to survival for early diagnosis, but there were insufficient data to analyse such differences among types of cancer. Clearly, the components of such disadvantage require further evaluation. A greater understanding is needed on the levels of utilisation of healthcare services and potential barriers to this among people with mental illness, including the extent to which this is present across individual cancer diagnoses and to which it is accounted for by the specific symptoms of the mental disorders themselves, by accompanying social disadvantage, or potentially by stigma. Also worthy of further evaluation is the potential impact that mental healthcare could have on improving physical health and other indirect influences of mental disorders on adverse health outcomes.
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